Philip Scumpia

Philip Scumpia

University of California, Los Angeles

H-index: 42

North America-United States

About Philip Scumpia

Philip Scumpia, With an exceptional h-index of 42 and a recent h-index of 30 (since 2020), a distinguished researcher at University of California, Los Angeles, specializes in the field of Immunology, Dermatology, Wound healing.

His recent articles reflect a diverse array of research interests and contributions to the field:

The transcription factor NF-κB orchestrates nucleosome remodeling during the primary response to Toll-like receptor 4 signaling

CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes

Biopsy analysis of trial S1616: Ipilimumab plus nivolumab versus ipilimumab alone in patients with anti-PD-1 refractory melanoma

A phase 1 study of triple‐targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF‐mutated cancers

Utilizing biopsy-free virtual histology for improved clinical efficiency in the dermatologic surgical setting

A Case of Perforating Folliculitis in a Peritoneal Dialysis Patient

Microporous annealed particle gel system

A novel microporous biomaterial vaccine platform for long-lasting antibody mediated immunity against viral infection.

Philip Scumpia Information

University

Position

Assistant Professor Division of Dermatology

Citations(all)

7265

Citations(since 2020)

3258

Cited By

5078

hIndex(all)

42

hIndex(since 2020)

30

i10Index(all)

68

i10Index(since 2020)

51

Email

University Profile Page

University of California, Los Angeles

Google Scholar

View Google Scholar Profile

Philip Scumpia Skills & Research Interests

Immunology

Dermatology

Wound healing

Top articles of Philip Scumpia

Title

Journal

Author(s)

Publication Date

The transcription factor NF-κB orchestrates nucleosome remodeling during the primary response to Toll-like receptor 4 signaling

Immunity

An-Chieh Feng

Brandon J Thomas

Prabhat K Purbey

Filipe Menegatti de Melo

Xin Liu

...

2024/3/1

CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes

Nature Communications

Sameeha Jilani

Justin D Saco

Edurne Mugarza

Aleida Pujol-Morcillo

Jeffrey Chokry

...

2024/2/9

Biopsy analysis of trial S1616: Ipilimumab plus nivolumab versus ipilimumab alone in patients with anti-PD-1 refractory melanoma

Cancer Research

Katie M Campbell

Zaid Bustami

Daniel G Chen

Egmidio Medina

Cynthia R Gonzalez

...

2024/3/22

A phase 1 study of triple‐targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF‐mutated cancers

Cancer

Alain P Algazi

James Moon

Christopher D Lao

Bartosz Chmielowski

Kari L Kendra

...

2024/1/23

Utilizing biopsy-free virtual histology for improved clinical efficiency in the dermatologic surgical setting

Cancer Research

Rachel Wahhab

Nelly Kokikian

Jingxi Li

Jason Garfinkel

Stephanie Martin

...

2024/3/22

A Case of Perforating Folliculitis in a Peritoneal Dialysis Patient

Clinical Practice and Cases in Emergency Medicine

Glenn Goodwin

Katherine L O'Neil

Megan Dekok

Moshe Bengio

Philip O Scumpia

...

2024/1/9

Microporous annealed particle gel system

2024/3/19

A novel microporous biomaterial vaccine platform for long-lasting antibody mediated immunity against viral infection.

bioRxiv

Daniel P Mayer

Mariah Nelson

Daria Andriyanova

Olivia Q Antao

Jennifer S Chen

...

2024

Microporous annealed particle gels and methods of use

2024/3/19

Injectable Microporous Annealed Crescent-Shaped (MAC) Particle Hydrogel Scaffold for Enhanced Cell Infiltration

Adv Healthc Mater

Rui-Chian Tang

Lily Shang

Philip Scumpia

Dino Di Carlo

2023/11/20

Engineering Immunomodulatory Biomaterials to Drive Skin Wounds toward Regenerative Healing

Sergei Butenko

Hiromi Miwa

Yingzi Liu

Maksim V Plikus

Phillip O Scumpia

...

2023/5/1

CD8 T cell-melanoma cell interactions in response and resistance to ipilimumab plus nivolumab: Biopsy analysis of SWOG S1616

Cancer Research

Katie M Campbell

Lawrence Kuklinski

Zaid Bustami

Jessica Maxey

Egmidio Medina

...

2023/4/4

Improved Humoral Immunity and Protection against Influenza Virus Infection with a 3d Porous Biomaterial Vaccine

Advanced Science

Hiromi Miwa

Olivia Q Antao

Kindra M Kelly‐Scumpia

Sevana Baghdasarian

Daniel P Mayer

...

2023/11

LXR Signaling Mediates Protection from Bacterial Toxins

The Journal of Immunology

Minsub S Lee

Alessandro Sammarco

Baolong Su

Kevin Williams

Loren Fong

...

2023/5/1

Label-free, in vivo virtual histology of skin using reflectance confocal microscopy and deep learning (Conference Presentation)

Jingxi Li

Jason Garfinkel

Xiaoran Zhang

Di Wu

Yijie Zhang

...

2023/3/16

LB1787 Tuning biomaterial stiffness augments innate and adaptive immune responses in the skin

Journal of Investigative Dermatology

KM Kelly-Scumpia

L Shang

JS Weinstein

D Di Carlo

PO Scumpia

2023/9/1

De novo tissue formation using custom microporous annealed particle hydrogel provides long-term vocal fold augmentation

NPJ Regenerative Medicine

Lauren J Pruett

Hannah L Kenny

William M Swift

Katarina J Catallo

Zoe R Apsel

...

2023/2/23

Multi-organ landscape of therapy-resistant melanoma

Nature medicine

Sixue Liu

Prashanthi Dharanipragada

Shirley H Lomeli

Yan Wang

Xiao Zhang

...

2023/5

Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial

Nature medicine

Ari VanderWalde

Shay L Bellasea

Kari L Kendra

Nikhil I Khushalani

Katie M Campbell

...

2023/9

IRF1 displays opposing tumor cell-intrinsic and-extrinsic roles in anti-tumor immunity

Cancer Research

Prabhat Kumar Purbey

Manash K Paul

Keisuke S Iwamoto

Allison Daly

Joowon Seo

...

2023/4/4

See List of Professors in Philip Scumpia University(University of California, Los Angeles)